| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Letters to the Editor |
Gastroenterological and Endocrinological Research Group Semmelweis University Medical School Budapest, Hungary
According to earlier studies, patients with nonhyperfunctioning adrenal adenomas often show an increased plasma 17-hydroxyprogesterone response to ACTH stimulation (1, 2, 3, 4, 5, 6, 7, 8, 9). In most studies the frequency of this hormonal abnormality ranged between 30% and 70%, probably reflecting the method used for the definition of normal 17-hydroxyprogesterone response. Although the meaning of increased plasma 17-hydroxyprogesterone response after ACTH stimulation in patients with nonhyperfunctioning adrenal adenomas has not been clearly elucidated, several reports considered this finding as an indication for the presence of a decreased activity of the steroid 21-hydroxylase enzyme (1, 2, 3, 4, 5, 6, 7). However, only very few patients were reinvestigated for this abnormality after surgical removal of these adenomas (3, 4, 5).
To address this question, we measured basal and ACTH-stimulated plasma 17-hydroxyprogesterone and cortisol concentrations in 78 patients with nonhyperfunctioning adrenal adenomas both before and after adrenal surgery, as well as in 60 healthy subjects. ACTH124 (Cortrosyn Depot, Organon) was given im at 1400 h, and blood was drawn the next morning for measurements of plasma cortisol and 17-hydroxyprogesterone.
ACTH-stimulated plasma 17-hydroxyprogesterone and cortisol levels
before adrenal surgery were significantly higher in patients with
nonhyperfunctioning adenomas compared with those found in healthy
subjects (17-hydroxyprogesterone, 1928 ± 215 vs.
601 ± 36 ng/dL, mean ± SE, P <
0.001; cortisol, 82.8 ± 5.7 vs. 46.3 ± 2.1
µg/dL, P < 0.001). None of the healthy subjects but
53% of patients with nonhyperfunctioning adrenal adenomas had
ACTH-stimulated plasma 17-hydroxyprogesterone concentrations higher
than 1500 ng/dL (Fig. 1
).In these patients, adrenal surgery resulted in a substantial decrease
of ACTH-stimulated plasma 17-hydroxyprogesterone (499 ± 54 ng/dL)
and cortisol concentrations (34.7 ± 2.3 µg/dL). In addition,
ACTH-stimulated plasma 17-hydroxyprogesterone and cortisol levels
showed significant positive correlations with the size of adenomas
(r = 0.27 between plasma 17-hydroxyprogesterone and tumor size,
P = 0.025; r = 0.40 between plasma cortisol and
tumor size, P < 0.001). Even stronger positive
correlation was found between the plasma 17-hydroxyprogesterone and
cortisol responses to ACTH (r = 0.50, P <
0.001).
|
Footnotes
Address correspondence to: Miklós Tóth, M.D., 2nd Department of Medicine, Semmelweis University Medical School, Szentkirályi u. 46., H-1088 Budapest, Hungary.
Received June 23, 1998.
References
-hydroxyprogesterone response to ACTH stimulation as evidence of
decreased 21-hydroxylase activity in patients with incidentally
discovered adrenal tumours ("incidentalomas"). Clin Endocrinol. 41:445451.[Medline]
-hydroxyprogesterone response to ACTH in silent
adrenal adenoma: cause or effect? Clin Endocrinol. 42:273277.[Medline]
This article has been cited by other articles:
![]() |
A. Thorin-Savoure, F. Tissier-Rible, L. Guignat, A. Pellerin, X. Bertagna, J. Bertherat, and H. Lefebvre Collision/Composite Tumors of the Adrenal Gland: A Pitfall of Scintigraphy Imaging and Hormone Assays in the Detection of Adrenal Metastasis J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4924 - 4929. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |